These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38563882)

  • 1. Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence.
    Li Y; Wang S; Zhao S; Zhao P; Huang S; Li K; Han S; Tian C; Li X; Shi B; Li X
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2458-2466. PubMed ID: 38563882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flare on [
    Malaspina S; Ettala O; Tolvanen T; Rajander J; Eskola O; Boström PJ; Kemppainen J
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):613-621. PubMed ID: 36161511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics.
    García-Zoghby L; Amo-Salas M; Soriano Castrejón ÁM; García Vicente AM
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2467-2483. PubMed ID: 38520513
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Mena E; Lindenberg ML; Turkbey IB; Shih JH; Harmon SA; Lim I; Lin F; Adler S; Eclarinal P; McKinney YL; Citrin D; Dahut W; Wood BJ; Krishnasamy V; Chang R; Levy E; Merino M; Pinto P; Eary JF; Choyke PL
    J Nucl Med; 2020 Jun; 61(6):881-889. PubMed ID: 31676732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Management After
    Ng M; Guerrieri M; Wong LM; Taubman K; Sutherland T; Benson A; Byrne G; Koschel S; Yap K; Starmans M; Ong G; Macleod C; Foo M; Chao M
    J Nucl Med; 2022 Sep; 63(9):1343-1348. PubMed ID: 35058320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [
    Roy J; White ME; Basuli F; Opina ACL; Wong K; Riba M; Ton AT; Zhang X; Jansson KH; Edmondson E; Butcher D; Lin FI; Choyke PL; Kelly K; Jagoda EM
    Mol Imaging Biol; 2021 Oct; 23(5):745-755. PubMed ID: 33891265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY
    Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Dietlein F; Mueller P; Kobe C; Endepols H; Hohberg M; Zlatopolskiy BD; Krapf P; Heidenreich A; Neumaier B; Drzezga A; Dietlein M
    Mol Imaging Biol; 2021 Apr; 23(2):277-286. PubMed ID: 33006028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUVs Are Adequate Measures of Lesional
    Bodar YJL; Koene BPF; Jansen BHE; Cysouw MCF; Meijer D; Hendrikse NH; Vis AN; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2021 Sep; 62(9):1264-1269. PubMed ID: 33509971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy.
    Liu W; Zukotynski K; Emmett L; Chung HT; Chung P; Wolfson R; Rachinsky I; Kapoor A; Metser U; Loblaw A; Morton G; Sexton T; Lock M; Helou J; Berlin A; Boylan C; Archer S; Pond GR; Bauman G
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):546-555. PubMed ID: 31730876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of
    Song H; Harrison C; Duan H; Guja K; Hatami N; Franc BL; Moradi F; Aparici CM; Davidzon GA; Iagaru A
    J Nucl Med; 2020 Apr; 61(4):546-551. PubMed ID: 31628216
    [No Abstract]   [Full Text] [Related]  

  • 13. Repeatability of Quantitative
    Jansen BHE; Cysouw MCF; Vis AN; van Moorselaar RJA; Voortman J; Bodar YJL; Schober PR; Hendrikse NH; Hoekstra OS; Boellaard R; Oprea-Lager DE
    J Nucl Med; 2020 Sep; 61(9):1320-1325. PubMed ID: 31924729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Evaluation of
    Gaur S; Mena E; Harmon SA; Lindenberg ML; Adler S; Ton AT; Shih JH; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Mease RC; Pomper MG; Choyke PL; Turkbey B
    AJR Am J Roentgenol; 2020 Sep; 215(3):652-659. PubMed ID: 32755168
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
    Dietlein M; Kobe C; Kuhnert G; Stockter S; Fischer T; Schomäcker K; Schmidt M; Dietlein F; Zlatopolskiy BD; Krapf P; Richarz R; Neubauer S; Drzezga A; Neumaier B
    Mol Imaging Biol; 2015 Aug; 17(4):575-84. PubMed ID: 26013479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with
    Ferraro DA; Rüschoff JH; Muehlematter UJ; Kranzbühler B; Müller J; Messerli M; Husmann L; Hermanns T; Eberli D; Rupp NJ; Burger IA
    Theranostics; 2020; 10(14):6082-6094. PubMed ID: 32483440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early lesion detection with
    Wondergem M; Jansen BHE; van der Zant FM; van der Sluis TM; Knol RJJ; van Kalmthout LWM; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1911-1918. PubMed ID: 31230088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of androgen deprivation therapy on
    Onal C; Guler OC; Torun N; Reyhan M; Yapar AF
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):632-641. PubMed ID: 31732768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with
    Ettala O; Malaspina S; Tuokkola T; Luoto P; Löyttyniemi E; Boström PJ; Kemppainen J
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):665-673. PubMed ID: 31879814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostate cancer with
    Bodar YJL; Jansen BHE; van der Voorn JP; Zwezerijnen GJC; Meijer D; Nieuwenhuijzen JA; Boellaard R; Hendrikse NH; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
    World J Urol; 2021 Jul; 39(7):2439-2446. PubMed ID: 33079250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.